| MPE | malignant proliferation of eosinophils; maximum permissible exposure; maximum possible error; Medicaid program evaluation |
|---|---|
| MPEC | monopolar electrocoagulation |
| MPED | minimum phototoxic erythema dose |
| MPEH | methylphenylethylhydantoin |
| MPE | Malignant pleural effusion |
|---|---|
| MPE | Massive pulmonary embolism |
| MPE | Mean prediction error |
| MPE | Methidiumpropyl-EDTA |
| MPE.Fe(II) | Methidiumpropyl-EDTA.Fe(II |
| MPEAK | MultiPeak |
| mPEG | Monomethoxy polyethylene glycol |
| MPEG | methoxy poly(ethylene glycol |
| MPEP | 2-methyl-6-(phenylethynyl)-pyridine |
| % MPE | Maximal possible effects |
|---|---|
| % MPE | maximum possible effect |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|